Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 13:9:813190.
doi: 10.3389/fcvm.2022.813190. eCollection 2022.

Platelet Aggregation Before Aspirin Initiation in Pediatric Patients With Congenital Heart Disease at High Risk of Thrombosis

Zhong-Yuan Lu  1 , Zhi-Yuan Zhu  1 , Ju-Xian Yang  1 , Yu-Zi Zhou  1 , Ya-Zhou Jiang  1 , Wei Wei  1 , Xu Wang  1 , Shou-Jun Li  2
Affiliations

Platelet Aggregation Before Aspirin Initiation in Pediatric Patients With Congenital Heart Disease at High Risk of Thrombosis

Zhong-Yuan Lu et al. Front Cardiovasc Med. .

Abstract

Background: Aspirin following unfractionated heparin is the most common anticoagulation strategy for pediatric patients who experienced cardiac surgery at high risk of thrombosis. The platelet aggregation test is the golden method to evaluate the aspirin effect on platelet function. However, the platelet aggregation basal status before postoperative aspirin initiation and the related clinical influencing factors hasn't been investigated systemically in this population.

Methods: In a prospective cohort of 247 children, arachidonic acid-induced platelet aggregation (PAG-AA) was measured by means of light transmission aggregometry (LTA) before the first dose of aspirin after cardiac surgical procedure and the perioperative variables were also collected. Distribution of this population's PAG-AA basal status was described. Univariate and multivariate logistic regression analysis were performed to identify the main influencing factors of PAG-AA.

Results: The median time of aspirin administration was 2 (1-27) days after surgery and the corresponding median value of basal PAG-AA was 20.70% (1.28-86.49%), with 67.6% population under 55% and 47.8% population under 20%. Patients undergoing cardiopulmonary bypass (CPB) had a significantly lower basal PAG-AA than those without (30.63 ± 27.35 vs. 57.91 ± 27.58, p = 0.013). While patients whose test done within 3 days after CPB had a significantly lower PAG-AA than those out of 3 days (25.61 ± 25.59 vs. 48.59 ± 26.45, p = 0.001). Univariate analysis implied that the influencing factors of the basal PAG-AA including CPB use, test time point, cyanosis, and platelet count. Multivariate regression analysis indicated that only CPB use, test time point, and platelet count were the main independent influencing factors for the basal PAG-AA.

Conclusion: The majority of children have impaired basal platelet aggregometry responses before postoperative aspirin initiation. The main influencing factors are CPB use, test time point, and platelet count. To establish the platelet aggregometry baseline prior to commencement of aspirin therapy, testing should be performed 3 days later following the procedure when effect of CPB is basically over.

Keywords: basal status; children; congenital heart disease; influencing factors; platelet aggregation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The scatterplot of basal arachidonic acid- induced platelet aggregation (PAG-AA) distribution.
Figure 2
Figure 2
Comparison of basal PAG-AA at different test time point.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Long E, Pitfield AF, Kissoon N. Anticoagulation therapy: indications, monitoring, and complications. Pediatr Emerg Care. (2011) 27:55–61. 10.1097/PEC.0b013e31820461b1 - DOI - PubMed
    1. Faustino EV, Hanson S, Spinella PC, Tucci M, O'Brien SH, Nunez AR, et al. . A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med. (2014) 42:1232–40. 10.1097/CCM.0000000000000147 - DOI - PMC - PubMed
    1. Li JS, Yow E, Berezny KY, Rhodes JF, Bokesch PM, Charpie JR, et al. . Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation. (2007) 116:293–7. 10.1161/CIRCULATIONAHA.106.652172 - DOI - PubMed
    1. Wessel DL, Berger F, Li JS, Dähnert I, Rakhit A, Fontecave S, et al. . Clopidogrel in infants with systemic-to-pulmonary-artery shunts. N Engl J Med. (2013) 368:2377–84. 10.1056/NEJMoa1114588 - DOI - PubMed
    1. Gnanappa GK, Celermajer DS, Sholler GF, Gentles T, Winlaw D, d'Udekem Y, et al. . The long-term management of children and adults with a Fontan circulation: a systematic review and survey of current practice in Australia and New Zealand. Pediatr Cardiol. (2017) 38:56–69. 10.1007/s00246-016-1484-6 - DOI - PubMed

LinkOut - more resources